The Challenge of pN3 Stage in Breast Cancer

@inproceedings{Gmez2016TheCO,
  title={The Challenge of pN3 Stage in Breast Cancer},
  author={A. G{\'o}mez},
  year={2016}
}
Since 1959 the American Joint Committee on Cancer (AJCC) TNM system has been used to stage breast cancer. Since then, the TNM has helped clinicians in deciding the better treatment for each patient [1]. Periodically revisions have been made to this classification with the aim of keeping a relationship between the disease extent and the prognosis. However, when we talk about breast cancer, the TNM is not always enough. Several publications in the last years report that there are other predictive… Expand
Types of Cancer and Surgery in Rats (Rattus norvegicus)
Breast Cancer in the United States: Fight the Fight

References

SHOWING 1-6 OF 6 REFERENCES
Prognostically Distinctive Subgroup in Pathologic N3 Breast Cancer
Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?
Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.
  • M. Yi, E. Mittendorf, +10 authors K. Hunt
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments.
Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy.